Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2006
05/04/2006US20060093575 Oxaliplatin anti-resistance agent
05/04/2006US20060093516 Analytical test piece and process for producing the same
05/04/2006US20060093200 Optical projection tomography
05/04/2006US20060093086 Moveable transparent barrier for x-ray analysis of a pressurized sample
05/04/2006US20060092760 Device for mixing and/or injecting cements
05/04/2006US20060091085 Microchip for sample, centrifugal dispension method of sample using the microchip and centrifugal dispenser
05/04/2006US20060091006 Analyte sensor with insertion monitor, and methods
05/04/2006US20060090539 Method of detecting high-concentration region direction of pollutant in soil
05/04/2006US20060090538 Bubble detection with temperature compensation
05/04/2006DE202006003578U1 Behältnis Container
05/04/2006DE202005020455U1 Piercing tool for safely extracting specific amount of DNA sample from purification gel, consisting of syringe-type body with syringe-type piston and terminal inlet tube of reduced cross-sectional area
05/04/2006DE19637741B4 Automatisches Zytologisches Probenanalysesystem unter Verwendung von individualisierten Patientendaten Cytologic automatic sample analysis system using individualized patient data
05/04/2006DE10260431B4 Verfahren zur selbstjustierenden Immobilisierung lebender Zellen auf einem Substrat auf Silizium-Basis A process for self-aligning the immobilization of living cells on a substrate based on silicon
05/04/2006DE10200654B4 Verfahren und Vorrichtung zum Messen des Strömungspotentials innerhalb einer faserstoffhaltigen Flüssigkeit Method and device for measuring the streaming potential within a fiber-containing liquid
05/04/2006DE102004053166A1 Vakuum-assistiertes Drainagesystem Vacuum-assisted drainage system
05/04/2006DE102004053064A1 Ionisierung durch Tröpfchenaufprall Ionization by droplet impact
05/04/2006DE102004052729A1 Immunkomplex-spezifsicher Antikörper zur Reduktion des Nullwerts beim Nachweis von Antigen-spezifisch gebundenen Antikörpern einer bestimmten Immunglobulinklasse in Array-Testformaten Immune complex spezifsicher antibodies to reduce the zero value in the detection of antigen-specific antibodies bound to a particular immunoglobulin class in array test formats
05/04/2006DE102004052039A1 Determination of melting depth during melting of a metal layer with one or more layer sites by means of a reflected test beam useful in metallurgical melting operations providing relaible and reproducible depth determination
05/04/2006DE102004051573A1 Waste liquid treatment in cartridges comprises injecting a liquid absorbent into a container, which is placed in a sealed chemical reaction cartridge, absorbing the chemicals and gelling dangerous substances such as pathogenic bacteria
05/04/2006DE102004051016A1 Verfahren und System zur Aufklärung der Primärstruktur von Biopolymeren Method and system for elucidation of the primary structure of biopolymers
05/04/2006DE102004022483B4 Halter für eine Aufnahmevorrichtung zum Aufnehmen von biologischen Objekten Holder for a receiving device for receiving biological objects
05/04/2006DE102004005710A1 Biosensor und Verfahren zu dessen Betrieb Biosensor and method of operation
05/04/2006CA2820140A1 Chlamydia trachomatis antigens for vaccine and diagnostic use
05/04/2006CA2754028A1 Identification of a jak2 mutation in polycythemia vera
05/04/2006CA2586511A1 Immunoassays for lamotrigine
05/04/2006CA2586506A1 Immunoassays for topiramate
05/04/2006CA2586466A1 Topiramate analogs
05/04/2006CA2585831A1 Applications of nucleic acid fragments
05/04/2006CA2585175A1 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
05/04/2006CA2585148A1 Method of examining alzheimer's disease and diagnostic reagent
05/04/2006CA2585011A1 Chlamydia trachomatis antigens for vaccine and diagnostic use
05/04/2006CA2585002A1 Rapid microfluidic assay for analyte interactions
05/04/2006CA2584804A1 Eph receptor tumor biomarkers
05/04/2006CA2584609A1 Methods and means for stimulating apoptotic cell phagocytosis
05/04/2006CA2584606A1 Sensor-dispensing device and mechanism for extracting sensor
05/04/2006CA2584565A1 Disease diagnosing system
05/04/2006CA2584489A1 Kaspp (lrrke) gene, its production and use for the detection and treatment of neurodegenerative disorders
05/04/2006CA2584162A1 Method and apparatus for determining an analyte concentration in a sample having interferents
05/04/2006CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain
05/04/2006CA2583193A1 Double hybrid system based on gene silencing by transcriptional interference
05/04/2006CA2578550A1 Reaction vessel
05/04/2006CA2525358A1 Nucleic acid labeling methods
05/03/2006EP1653233A1 Method for determining antibodies of a particular class using an immune complex-specific antibody
05/03/2006EP1653232A1 Method for quantitative evaluation of bead-based affinity assays
05/03/2006EP1653227A1 Device and method of detecting flow rate/liquid kind, and device and method of detecting liquid kind
05/03/2006EP1653225A1 Device for detecting flaws and/or foreign material in yarn or textile web
05/03/2006EP1653220A2 Biochip reader
05/03/2006EP1653215A1 Method for accelerated measurement of fading characteristics of recording media, as well as recording media
05/03/2006EP1653214A1 Method for determining the properties of fibrous pulp
05/03/2006EP1652947A1 LOW Co HYDROGEN OCCLUSION ALLOY
05/03/2006EP1652934A1 Improved method of amplifying atp and use thereof
05/03/2006EP1652925A1 IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION
05/03/2006EP1652924A2 Polypeptide, cDNA encoding the same and use thereof
05/03/2006EP1652923A1 Gene overexpressed in cancer
05/03/2006EP1652918A2 Methods for detecting protein interactions using conformationally constrained peptides
05/03/2006EP1652858A1 Peptides for inducing a CTL and/or HTL response to hepatitis C virus
05/03/2006EP1652839A2 Drug efflux pump inhibitor
05/03/2006EP1652067A2 Optical method for evaluating surface and physical properties of structures made wholly or partially from fibers, films, polymers or a combination thereof
05/03/2006EP1651964A2 Methods and kits for the detection of prion diseases
05/03/2006EP1651963A2 Monocarboxylate transporters expressed in cancer cells
05/03/2006EP1651961A1 Biochemical diagnostic means for screening for rheumatoid arthritis
05/03/2006EP1651960A1 Use of magnetic particles for determining binding between bioactive molecules
05/03/2006EP1651959A2 Molecular probe and material for the detection of an analyte, and use thereof
05/03/2006EP1651958A1 Novel chemiluminescent compounds and their use
05/03/2006EP1651957A1 Fluorescent magnetic nanoparticles and process of preparation
05/03/2006EP1651956A2 Melks as modifiers of the rac pathway and methods of use
05/03/2006EP1651955A2 Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials
05/03/2006EP1651954A1 Method and device for measuring the strip mass and/or variations in the strip mass of a running fiber assembly and spinning preparation machine equipped with a measuring device
05/03/2006EP1651944A1 Viscosity sensor assembly
05/03/2006EP1651809A1 Isolation of sclereids
05/03/2006EP1651775A2 Breast cancer survival and recurrence
05/03/2006EP1651771A2 Neural cell assay
05/03/2006EP1651759A1 Methods and compositions for determination of glycated proteins
05/03/2006EP1651755A2 Method for immunotherapy of tumors
05/03/2006EP1651752A2 Methods of inhibiting cancer growth by binding to nuclear receptors
05/03/2006EP1651751A2 Engineered proteases for affinity purification and processing of fusion proteins
05/03/2006EP1651674A2 Ups as modifiers of the beta catenin pathway and methods of use
05/03/2006EP1651671A2 Epha2 t-cell epitope agonists and uses therefor
05/03/2006EP1651663A2 Bispecific antibodies for inducing apoptosis of tumor and diseased cells
05/03/2006EP1651636A1 Substituted heterocyclic diarylamine analogues
05/03/2006EP1651268A2 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa
05/03/2006EP1651247A1 Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin
05/03/2006EP1651225A1 High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
05/03/2006EP1651198A2 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
05/03/2006EP1651095A2 ErbB RECEPTOR METHODS AND KITS FOR MONITORING CHEMOTHERAPY RESISTANCE
05/03/2006EP1651038A2 Tissue adhesive sealant
05/03/2006EP1573316A4 Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (egfr) extracellular domain (ecd) analyte, alone or in combination with other analytes, in body fluid samples
05/03/2006EP1549758A4 Feline pancreatic lipase composition and method of preparing and using such composition
05/03/2006EP1490486A4 Method of identifying genes controlling diferentiation
05/03/2006EP1488007A4 Gene expression profiling in biopsied tumor tissues
05/03/2006EP1485708A4 Method for analyzing impurities in carbon dioxide
05/03/2006EP1483794A4 Latex based adsorbent chip
05/03/2006EP1483586A4 Immunoassays for beta2-microglobulin
05/03/2006EP1478395A4 Rapid lateral flow assay for determining exposure to mycobacterium tuberculosis and other mycobacteria
05/03/2006EP1457773B1 Electrode for active oxygen species and sensor using the electrode
05/03/2006EP1451377A4 Assay for identifying anti-viral agents specific for protein-coated double-stranded dna viruses
05/03/2006EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
05/03/2006EP1425046A4 Wild-type ras as a cancer therapeutic agent
05/03/2006EP1389129A4 Methods of treating respiratory conditions
05/03/2006EP1388010A4 Arrays of biological membranes and methods and use thereof